Global Tumour Ablation Devices Supply, Demand and Key Producers, 2026-2032
The global Tumour Ablation Devices market size is expected to reach $ 5594 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Tumour ablation devices are minimally invasive medical systems that deliver controlled thermal or non-thermal energy—such as radiofrequency, microwave, or cryogenic energy—directly into tumor tissues to induce irreversible cell death. These systems typically consist of energy generators, applicators (needles or probes), and imaging-guided monitoring modules, enabling precise targeting under ultrasound, CT, or MRI guidance. Widely used in treating solid tumors such as liver, lung, and kidney cancers, these devices offer advantages including minimal trauma, rapid recovery, and repeatability. They have become a core modality in interventional oncology and are increasingly expanding from adjunctive roles toward curative applications in early-stage cancers, driving the shift toward precision and minimally invasive cancer care. The average gross profit margin of this product is 72%.
With the rising incidence of cancer and the advancement of early screening systems, treatment paradigms are shifting from late-stage intervention to early precision therapy, creating strong growth opportunities for ablation devices. Government initiatives promoting tiered healthcare systems, minimally invasive procedures, and outpatient surgery are accelerating adoption across hospitals and specialty centers. Meanwhile, rapid advancements in RF, microwave, and cryo technologies, combined with imaging navigation and digital platforms, are significantly enhancing precision and safety, enabling ablation devices to transition from alternative therapies to standard-of-care solutions.The industry faces challenges including inconsistent clinical standards and limitations in treating complex or large tumors, where outcomes can vary and depend heavily on operator expertise. High equipment and maintenance costs, along with lagging reimbursement policies and clinical guideline updates, constrain market expansion in certain regions. Additionally, competition from surgery, radiotherapy, and targeted therapies continues to impact adoption rates.Clinical practice is rapidly shifting toward multidisciplinary and minimally invasive treatment models, with expanding applications in liver cancer, lung nodules, and thyroid diseases. Increasing patient emphasis on reduced trauma, faster recovery, and quality of life is driving demand for outpatient and repeatable procedures. Furthermore, the chronic disease management model in oncology is reinforcing the role of ablation devices in recurrence control and palliative care, generating sustained demand for both capital equipment and consumables.Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to energy stability and clinical safety. While localization of electronic components and precision manufacturing is improving cost efficiency, high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated system solutions, with upstream players transitioning from component suppliers to comprehensive solution providers, enhancing value capture and competitiveness.
This report studies the global Tumour Ablation Devices demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumour Ablation Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumour Ablation Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumour Ablation Devices total market, 2021-2032, (USD Million)
Global Tumour Ablation Devices total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Tumour Ablation Devices total market, key domestic companies, and share, (USD Million)
Global Tumour Ablation Devices revenue by player, revenue and market share 2021-2026, (USD Million)
Global Tumour Ablation Devices total market by Type, CAGR, 2021-2032, (USD Million)
Global Tumour Ablation Devices total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Tumour Ablation Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Tumour Ablation Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tumour Ablation Devices Market, By Region:
1. How big is the global Tumour Ablation Devices market?
2. What is the demand of the global Tumour Ablation Devices market?
3. What is the year over year growth of the global Tumour Ablation Devices market?
4. What is the total value of the global Tumour Ablation Devices market?
5. Who are the Major Players in the global Tumour Ablation Devices market?
6. What are the growth factors driving the market demand?
Tumour ablation devices are minimally invasive medical systems that deliver controlled thermal or non-thermal energy—such as radiofrequency, microwave, or cryogenic energy—directly into tumor tissues to induce irreversible cell death. These systems typically consist of energy generators, applicators (needles or probes), and imaging-guided monitoring modules, enabling precise targeting under ultrasound, CT, or MRI guidance. Widely used in treating solid tumors such as liver, lung, and kidney cancers, these devices offer advantages including minimal trauma, rapid recovery, and repeatability. They have become a core modality in interventional oncology and are increasingly expanding from adjunctive roles toward curative applications in early-stage cancers, driving the shift toward precision and minimally invasive cancer care. The average gross profit margin of this product is 72%.
With the rising incidence of cancer and the advancement of early screening systems, treatment paradigms are shifting from late-stage intervention to early precision therapy, creating strong growth opportunities for ablation devices. Government initiatives promoting tiered healthcare systems, minimally invasive procedures, and outpatient surgery are accelerating adoption across hospitals and specialty centers. Meanwhile, rapid advancements in RF, microwave, and cryo technologies, combined with imaging navigation and digital platforms, are significantly enhancing precision and safety, enabling ablation devices to transition from alternative therapies to standard-of-care solutions.The industry faces challenges including inconsistent clinical standards and limitations in treating complex or large tumors, where outcomes can vary and depend heavily on operator expertise. High equipment and maintenance costs, along with lagging reimbursement policies and clinical guideline updates, constrain market expansion in certain regions. Additionally, competition from surgery, radiotherapy, and targeted therapies continues to impact adoption rates.Clinical practice is rapidly shifting toward multidisciplinary and minimally invasive treatment models, with expanding applications in liver cancer, lung nodules, and thyroid diseases. Increasing patient emphasis on reduced trauma, faster recovery, and quality of life is driving demand for outpatient and repeatable procedures. Furthermore, the chronic disease management model in oncology is reinforcing the role of ablation devices in recurrence control and palliative care, generating sustained demand for both capital equipment and consumables.Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to energy stability and clinical safety. While localization of electronic components and precision manufacturing is improving cost efficiency, high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated system solutions, with upstream players transitioning from component suppliers to comprehensive solution providers, enhancing value capture and competitiveness.
This report studies the global Tumour Ablation Devices demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumour Ablation Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumour Ablation Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumour Ablation Devices total market, 2021-2032, (USD Million)
Global Tumour Ablation Devices total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Tumour Ablation Devices total market, key domestic companies, and share, (USD Million)
Global Tumour Ablation Devices revenue by player, revenue and market share 2021-2026, (USD Million)
Global Tumour Ablation Devices total market by Type, CAGR, 2021-2032, (USD Million)
Global Tumour Ablation Devices total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Tumour Ablation Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Tumour Ablation Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tumour Ablation Devices Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Other
- Thermal
- Cryogenic
- Percutaneous
- Laparoscopic
- Open
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other
- Chongqing Haifu Medical
- AngioDynamics
- Boston Scientific
- Medtronic
- Yigao Medical
- Haijieya
- Beijing Weierfu
- Micro Tech Medical
- Better Medical
- Vison Medical
- Shanghai Maide
- HealthTronics
- J &J
- EDAP TMS
- Sonacare Medical
- Misonix
1. How big is the global Tumour Ablation Devices market?
2. What is the demand of the global Tumour Ablation Devices market?
3. What is the year over year growth of the global Tumour Ablation Devices market?
4. What is the total value of the global Tumour Ablation Devices market?
5. Who are the Major Players in the global Tumour Ablation Devices market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tumour Ablation Devices Introduction
1.2 World Tumour Ablation Devices Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Tumour Ablation Devices Total Market by Region (by Headquarter Location)
1.3.1 World Tumour Ablation Devices Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.3 China Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.4 Europe Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.5 Japan Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.6 South Korea Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.7 ASEAN Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.8 India Based Company Tumour Ablation Devices Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumour Ablation Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Tumour Ablation Devices Consumption Value (2021-2032)
2.2 World Tumour Ablation Devices Consumption Value by Region
2.2.1 World Tumour Ablation Devices Consumption Value by Region (2021-2026)
2.2.2 World Tumour Ablation Devices Consumption Value Forecast by Region (2027-2032)
2.3 United States Tumour Ablation Devices Consumption Value (2021-2032)
2.4 China Tumour Ablation Devices Consumption Value (2021-2032)
2.5 Europe Tumour Ablation Devices Consumption Value (2021-2032)
2.6 Japan Tumour Ablation Devices Consumption Value (2021-2032)
2.7 South Korea Tumour Ablation Devices Consumption Value (2021-2032)
2.8 ASEAN Tumour Ablation Devices Consumption Value (2021-2032)
2.9 India Tumour Ablation Devices Consumption Value (2021-2032)
3 WORLD TUMOUR ABLATION DEVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumour Ablation Devices Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumour Ablation Devices Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumour Ablation Devices in 2025
3.2.3 Global Concentration Ratios (CR8) for Tumour Ablation Devices in 2025
3.3 Tumour Ablation Devices Company Evaluation Quadrant
3.4 Tumour Ablation Devices Market: Overall Company Footprint Analysis
3.4.1 Tumour Ablation Devices Market: Region Footprint
3.4.2 Tumour Ablation Devices Market: Company Product Type Footprint
3.4.3 Tumour Ablation Devices Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumour Ablation Devices Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumour Ablation Devices Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Tumour Ablation Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Tumour Ablation Devices Consumption Value Comparison
4.2.1 United States VS China: Tumour Ablation Devices Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tumour Ablation Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Tumour Ablation Devices Companies and Market Share, 2021-2026
4.3.1 United States Based Tumour Ablation Devices Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumour Ablation Devices Revenue, (2021-2026)
4.4 China Based Companies Tumour Ablation Devices Revenue and Market Share, 2021-2026
4.4.1 China Based Tumour Ablation Devices Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumour Ablation Devices Revenue, (2021-2026)
4.5 Rest of World Based Tumour Ablation Devices Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Tumour Ablation Devices Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumour Ablation Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Radiofrequency Ablation
5.2.2 Microwave Ablation
5.2.3 Cryoablation
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Tumour Ablation Devices Market Size by Type (2021-2026)
5.3.2 World Tumour Ablation Devices Market Size by Type (2027-2032)
5.3.3 World Tumour Ablation Devices Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ENERGY SOURCE
6.1 World Tumour Ablation Devices Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Source
6.2.1 Thermal
6.2.2 Cryogenic
6.3 Market Segment by Energy Source
6.3.1 World Tumour Ablation Devices Market Size by Energy Source (2021-2026)
6.3.2 World Tumour Ablation Devices Market Size by Energy Source (2027-2032)
6.3.3 World Tumour Ablation Devices Market Size Market Share by Energy Source (2027-2032)
7 MARKET ANALYSIS BY PROCEDURE TYPE
7.1 World Tumour Ablation Devices Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Procedure Type
7.2.1 Percutaneous
7.2.2 Laparoscopic
7.2.3 Open
7.3 Market Segment by Procedure Type
7.3.1 World Tumour Ablation Devices Market Size by Procedure Type (2021-2026)
7.3.2 World Tumour Ablation Devices Market Size by Procedure Type (2027-2032)
7.3.3 World Tumour Ablation Devices Market Size Market Share by Procedure Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Tumour Ablation Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Liver Cancer
8.2.2 Lung Cancer
8.2.3 Breast Cancer
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Tumour Ablation Devices Market Size by Application (2021-2026)
8.3.2 World Tumour Ablation Devices Market Size by Application (2027-2032)
8.3.3 World Tumour Ablation Devices Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Chongqing Haifu Medical
9.1.1 Chongqing Haifu Medical Details
9.1.2 Chongqing Haifu Medical Major Business
9.1.3 Chongqing Haifu Medical Tumour Ablation Devices Product and Services
9.1.4 Chongqing Haifu Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Chongqing Haifu Medical Recent Developments/Updates
9.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
9.2 AngioDynamics
9.2.1 AngioDynamics Details
9.2.2 AngioDynamics Major Business
9.2.3 AngioDynamics Tumour Ablation Devices Product and Services
9.2.4 AngioDynamics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 AngioDynamics Recent Developments/Updates
9.2.6 AngioDynamics Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Tumour Ablation Devices Product and Services
9.3.4 Boston Scientific Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 Medtronic
9.4.1 Medtronic Details
9.4.2 Medtronic Major Business
9.4.3 Medtronic Tumour Ablation Devices Product and Services
9.4.4 Medtronic Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medtronic Recent Developments/Updates
9.4.6 Medtronic Competitive Strengths & Weaknesses
9.5 Yigao Medical
9.5.1 Yigao Medical Details
9.5.2 Yigao Medical Major Business
9.5.3 Yigao Medical Tumour Ablation Devices Product and Services
9.5.4 Yigao Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yigao Medical Recent Developments/Updates
9.5.6 Yigao Medical Competitive Strengths & Weaknesses
9.6 Haijieya
9.6.1 Haijieya Details
9.6.2 Haijieya Major Business
9.6.3 Haijieya Tumour Ablation Devices Product and Services
9.6.4 Haijieya Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Haijieya Recent Developments/Updates
9.6.6 Haijieya Competitive Strengths & Weaknesses
9.7 Beijing Weierfu
9.7.1 Beijing Weierfu Details
9.7.2 Beijing Weierfu Major Business
9.7.3 Beijing Weierfu Tumour Ablation Devices Product and Services
9.7.4 Beijing Weierfu Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beijing Weierfu Recent Developments/Updates
9.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
9.8 Micro Tech Medical
9.8.1 Micro Tech Medical Details
9.8.2 Micro Tech Medical Major Business
9.8.3 Micro Tech Medical Tumour Ablation Devices Product and Services
9.8.4 Micro Tech Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Micro Tech Medical Recent Developments/Updates
9.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
9.9 Better Medical
9.9.1 Better Medical Details
9.9.2 Better Medical Major Business
9.9.3 Better Medical Tumour Ablation Devices Product and Services
9.9.4 Better Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Better Medical Recent Developments/Updates
9.9.6 Better Medical Competitive Strengths & Weaknesses
9.10 Vison Medical
9.10.1 Vison Medical Details
9.10.2 Vison Medical Major Business
9.10.3 Vison Medical Tumour Ablation Devices Product and Services
9.10.4 Vison Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vison Medical Recent Developments/Updates
9.10.6 Vison Medical Competitive Strengths & Weaknesses
9.11 Shanghai Maide
9.11.1 Shanghai Maide Details
9.11.2 Shanghai Maide Major Business
9.11.3 Shanghai Maide Tumour Ablation Devices Product and Services
9.11.4 Shanghai Maide Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Shanghai Maide Recent Developments/Updates
9.11.6 Shanghai Maide Competitive Strengths & Weaknesses
9.12 HealthTronics
9.12.1 HealthTronics Details
9.12.2 HealthTronics Major Business
9.12.3 HealthTronics Tumour Ablation Devices Product and Services
9.12.4 HealthTronics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HealthTronics Recent Developments/Updates
9.12.6 HealthTronics Competitive Strengths & Weaknesses
9.13 J &J
9.13.1 J &J Details
9.13.2 J &J Major Business
9.13.3 J &J Tumour Ablation Devices Product and Services
9.13.4 J &J Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 J &J Recent Developments/Updates
9.13.6 J &J Competitive Strengths & Weaknesses
9.14 EDAP TMS
9.14.1 EDAP TMS Details
9.14.2 EDAP TMS Major Business
9.14.3 EDAP TMS Tumour Ablation Devices Product and Services
9.14.4 EDAP TMS Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EDAP TMS Recent Developments/Updates
9.14.6 EDAP TMS Competitive Strengths & Weaknesses
9.15 Sonacare Medical
9.15.1 Sonacare Medical Details
9.15.2 Sonacare Medical Major Business
9.15.3 Sonacare Medical Tumour Ablation Devices Product and Services
9.15.4 Sonacare Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sonacare Medical Recent Developments/Updates
9.15.6 Sonacare Medical Competitive Strengths & Weaknesses
9.16 Misonix
9.16.1 Misonix Details
9.16.2 Misonix Major Business
9.16.3 Misonix Tumour Ablation Devices Product and Services
9.16.4 Misonix Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Misonix Recent Developments/Updates
9.16.6 Misonix Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Tumour Ablation Devices Industry Chain
10.2 Tumour Ablation Devices Upstream Analysis
10.3 Tumour Ablation Devices Midstream Analysis
10.4 Tumour Ablation Devices Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Tumour Ablation Devices Introduction
1.2 World Tumour Ablation Devices Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Tumour Ablation Devices Total Market by Region (by Headquarter Location)
1.3.1 World Tumour Ablation Devices Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.3 China Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.4 Europe Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.5 Japan Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.6 South Korea Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.7 ASEAN Based Company Tumour Ablation Devices Revenue (2021-2032)
1.3.8 India Based Company Tumour Ablation Devices Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumour Ablation Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Tumour Ablation Devices Consumption Value (2021-2032)
2.2 World Tumour Ablation Devices Consumption Value by Region
2.2.1 World Tumour Ablation Devices Consumption Value by Region (2021-2026)
2.2.2 World Tumour Ablation Devices Consumption Value Forecast by Region (2027-2032)
2.3 United States Tumour Ablation Devices Consumption Value (2021-2032)
2.4 China Tumour Ablation Devices Consumption Value (2021-2032)
2.5 Europe Tumour Ablation Devices Consumption Value (2021-2032)
2.6 Japan Tumour Ablation Devices Consumption Value (2021-2032)
2.7 South Korea Tumour Ablation Devices Consumption Value (2021-2032)
2.8 ASEAN Tumour Ablation Devices Consumption Value (2021-2032)
2.9 India Tumour Ablation Devices Consumption Value (2021-2032)
3 WORLD TUMOUR ABLATION DEVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumour Ablation Devices Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumour Ablation Devices Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumour Ablation Devices in 2025
3.2.3 Global Concentration Ratios (CR8) for Tumour Ablation Devices in 2025
3.3 Tumour Ablation Devices Company Evaluation Quadrant
3.4 Tumour Ablation Devices Market: Overall Company Footprint Analysis
3.4.1 Tumour Ablation Devices Market: Region Footprint
3.4.2 Tumour Ablation Devices Market: Company Product Type Footprint
3.4.3 Tumour Ablation Devices Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumour Ablation Devices Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumour Ablation Devices Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Tumour Ablation Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Tumour Ablation Devices Consumption Value Comparison
4.2.1 United States VS China: Tumour Ablation Devices Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tumour Ablation Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Tumour Ablation Devices Companies and Market Share, 2021-2026
4.3.1 United States Based Tumour Ablation Devices Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumour Ablation Devices Revenue, (2021-2026)
4.4 China Based Companies Tumour Ablation Devices Revenue and Market Share, 2021-2026
4.4.1 China Based Tumour Ablation Devices Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumour Ablation Devices Revenue, (2021-2026)
4.5 Rest of World Based Tumour Ablation Devices Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Tumour Ablation Devices Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumour Ablation Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Radiofrequency Ablation
5.2.2 Microwave Ablation
5.2.3 Cryoablation
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Tumour Ablation Devices Market Size by Type (2021-2026)
5.3.2 World Tumour Ablation Devices Market Size by Type (2027-2032)
5.3.3 World Tumour Ablation Devices Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ENERGY SOURCE
6.1 World Tumour Ablation Devices Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Energy Source
6.2.1 Thermal
6.2.2 Cryogenic
6.3 Market Segment by Energy Source
6.3.1 World Tumour Ablation Devices Market Size by Energy Source (2021-2026)
6.3.2 World Tumour Ablation Devices Market Size by Energy Source (2027-2032)
6.3.3 World Tumour Ablation Devices Market Size Market Share by Energy Source (2027-2032)
7 MARKET ANALYSIS BY PROCEDURE TYPE
7.1 World Tumour Ablation Devices Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Procedure Type
7.2.1 Percutaneous
7.2.2 Laparoscopic
7.2.3 Open
7.3 Market Segment by Procedure Type
7.3.1 World Tumour Ablation Devices Market Size by Procedure Type (2021-2026)
7.3.2 World Tumour Ablation Devices Market Size by Procedure Type (2027-2032)
7.3.3 World Tumour Ablation Devices Market Size Market Share by Procedure Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Tumour Ablation Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Liver Cancer
8.2.2 Lung Cancer
8.2.3 Breast Cancer
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Tumour Ablation Devices Market Size by Application (2021-2026)
8.3.2 World Tumour Ablation Devices Market Size by Application (2027-2032)
8.3.3 World Tumour Ablation Devices Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Chongqing Haifu Medical
9.1.1 Chongqing Haifu Medical Details
9.1.2 Chongqing Haifu Medical Major Business
9.1.3 Chongqing Haifu Medical Tumour Ablation Devices Product and Services
9.1.4 Chongqing Haifu Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Chongqing Haifu Medical Recent Developments/Updates
9.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
9.2 AngioDynamics
9.2.1 AngioDynamics Details
9.2.2 AngioDynamics Major Business
9.2.3 AngioDynamics Tumour Ablation Devices Product and Services
9.2.4 AngioDynamics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 AngioDynamics Recent Developments/Updates
9.2.6 AngioDynamics Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Tumour Ablation Devices Product and Services
9.3.4 Boston Scientific Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 Medtronic
9.4.1 Medtronic Details
9.4.2 Medtronic Major Business
9.4.3 Medtronic Tumour Ablation Devices Product and Services
9.4.4 Medtronic Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Medtronic Recent Developments/Updates
9.4.6 Medtronic Competitive Strengths & Weaknesses
9.5 Yigao Medical
9.5.1 Yigao Medical Details
9.5.2 Yigao Medical Major Business
9.5.3 Yigao Medical Tumour Ablation Devices Product and Services
9.5.4 Yigao Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yigao Medical Recent Developments/Updates
9.5.6 Yigao Medical Competitive Strengths & Weaknesses
9.6 Haijieya
9.6.1 Haijieya Details
9.6.2 Haijieya Major Business
9.6.3 Haijieya Tumour Ablation Devices Product and Services
9.6.4 Haijieya Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Haijieya Recent Developments/Updates
9.6.6 Haijieya Competitive Strengths & Weaknesses
9.7 Beijing Weierfu
9.7.1 Beijing Weierfu Details
9.7.2 Beijing Weierfu Major Business
9.7.3 Beijing Weierfu Tumour Ablation Devices Product and Services
9.7.4 Beijing Weierfu Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Beijing Weierfu Recent Developments/Updates
9.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
9.8 Micro Tech Medical
9.8.1 Micro Tech Medical Details
9.8.2 Micro Tech Medical Major Business
9.8.3 Micro Tech Medical Tumour Ablation Devices Product and Services
9.8.4 Micro Tech Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Micro Tech Medical Recent Developments/Updates
9.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
9.9 Better Medical
9.9.1 Better Medical Details
9.9.2 Better Medical Major Business
9.9.3 Better Medical Tumour Ablation Devices Product and Services
9.9.4 Better Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Better Medical Recent Developments/Updates
9.9.6 Better Medical Competitive Strengths & Weaknesses
9.10 Vison Medical
9.10.1 Vison Medical Details
9.10.2 Vison Medical Major Business
9.10.3 Vison Medical Tumour Ablation Devices Product and Services
9.10.4 Vison Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vison Medical Recent Developments/Updates
9.10.6 Vison Medical Competitive Strengths & Weaknesses
9.11 Shanghai Maide
9.11.1 Shanghai Maide Details
9.11.2 Shanghai Maide Major Business
9.11.3 Shanghai Maide Tumour Ablation Devices Product and Services
9.11.4 Shanghai Maide Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Shanghai Maide Recent Developments/Updates
9.11.6 Shanghai Maide Competitive Strengths & Weaknesses
9.12 HealthTronics
9.12.1 HealthTronics Details
9.12.2 HealthTronics Major Business
9.12.3 HealthTronics Tumour Ablation Devices Product and Services
9.12.4 HealthTronics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HealthTronics Recent Developments/Updates
9.12.6 HealthTronics Competitive Strengths & Weaknesses
9.13 J &J
9.13.1 J &J Details
9.13.2 J &J Major Business
9.13.3 J &J Tumour Ablation Devices Product and Services
9.13.4 J &J Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 J &J Recent Developments/Updates
9.13.6 J &J Competitive Strengths & Weaknesses
9.14 EDAP TMS
9.14.1 EDAP TMS Details
9.14.2 EDAP TMS Major Business
9.14.3 EDAP TMS Tumour Ablation Devices Product and Services
9.14.4 EDAP TMS Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EDAP TMS Recent Developments/Updates
9.14.6 EDAP TMS Competitive Strengths & Weaknesses
9.15 Sonacare Medical
9.15.1 Sonacare Medical Details
9.15.2 Sonacare Medical Major Business
9.15.3 Sonacare Medical Tumour Ablation Devices Product and Services
9.15.4 Sonacare Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Sonacare Medical Recent Developments/Updates
9.15.6 Sonacare Medical Competitive Strengths & Weaknesses
9.16 Misonix
9.16.1 Misonix Details
9.16.2 Misonix Major Business
9.16.3 Misonix Tumour Ablation Devices Product and Services
9.16.4 Misonix Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Misonix Recent Developments/Updates
9.16.6 Misonix Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Tumour Ablation Devices Industry Chain
10.2 Tumour Ablation Devices Upstream Analysis
10.3 Tumour Ablation Devices Midstream Analysis
10.4 Tumour Ablation Devices Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Tumour Ablation Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Tumour Ablation Devices Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Tumour Ablation Devices Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Tumour Ablation Devices Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Tumour Ablation Devices Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumour Ablation Devices Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Tumour Ablation Devices Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Tumour Ablation Devices Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Tumour Ablation Devices Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Tumour Ablation Devices Players in 2025
Table 12. World Tumour Ablation Devices Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Tumour Ablation Devices Company Evaluation Quadrant
Table 14. Head Office of Key Tumour Ablation Devices Players
Table 15. Tumour Ablation Devices Market: Company Product Type Footprint
Table 16. Tumour Ablation Devices Market: Company Product Application Footprint
Table 17. Tumour Ablation Devices Mergers & Acquisitions Activity
Table 18. United States VS China Tumour Ablation Devices Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Tumour Ablation Devices Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Tumour Ablation Devices Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumour Ablation Devices Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 23. China Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumour Ablation Devices Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 26. Rest of World Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Tumour Ablation Devices Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 29. World Tumour Ablation Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Tumour Ablation Devices Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Tumour Ablation Devices Market Size by Type (2027-2032) & (USD Million)
Table 32. World Tumour Ablation Devices Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Tumour Ablation Devices Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 34. World Tumour Ablation Devices Market Size by Energy Source (2027-2032) & (USD Million)
Table 35. World Tumour Ablation Devices Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Tumour Ablation Devices Market Size Value by Procedure Type (2021-2026) & (USD Million)
Table 37. World Tumour Ablation Devices Market Size by Procedure Type (2027-2032) & (USD Million)
Table 38. World Tumour Ablation Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Tumour Ablation Devices Market Size by Application (2021-2026) & (USD Million)
Table 40. World Tumour Ablation Devices Market Size by Application (2027-2032) & (USD Million)
Table 41. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 42. Chongqing Haifu Medical Major Business
Table 43. Chongqing Haifu Medical Tumour Ablation Devices Product and Services
Table 44. Chongqing Haifu Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Chongqing Haifu Medical Recent Developments/Updates
Table 46. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 47. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 48. AngioDynamics Major Business
Table 49. AngioDynamics Tumour Ablation Devices Product and Services
Table 50. AngioDynamics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. AngioDynamics Recent Developments/Updates
Table 52. AngioDynamics Competitive Strengths & Weaknesses
Table 53. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Boston Scientific Major Business
Table 55. Boston Scientific Tumour Ablation Devices Product and Services
Table 56. Boston Scientific Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boston Scientific Recent Developments/Updates
Table 58. Boston Scientific Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Manufacturing Base and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Tumour Ablation Devices Product and Services
Table 62. Medtronic Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 66. Yigao Medical Major Business
Table 67. Yigao Medical Tumour Ablation Devices Product and Services
Table 68. Yigao Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yigao Medical Recent Developments/Updates
Table 70. Yigao Medical Competitive Strengths & Weaknesses
Table 71. Haijieya Basic Information, Manufacturing Base and Competitors
Table 72. Haijieya Major Business
Table 73. Haijieya Tumour Ablation Devices Product and Services
Table 74. Haijieya Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Haijieya Recent Developments/Updates
Table 76. Haijieya Competitive Strengths & Weaknesses
Table 77. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 78. Beijing Weierfu Major Business
Table 79. Beijing Weierfu Tumour Ablation Devices Product and Services
Table 80. Beijing Weierfu Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beijing Weierfu Recent Developments/Updates
Table 82. Beijing Weierfu Competitive Strengths & Weaknesses
Table 83. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 84. Micro Tech Medical Major Business
Table 85. Micro Tech Medical Tumour Ablation Devices Product and Services
Table 86. Micro Tech Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Micro Tech Medical Recent Developments/Updates
Table 88. Micro Tech Medical Competitive Strengths & Weaknesses
Table 89. Better Medical Basic Information, Manufacturing Base and Competitors
Table 90. Better Medical Major Business
Table 91. Better Medical Tumour Ablation Devices Product and Services
Table 92. Better Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Better Medical Recent Developments/Updates
Table 94. Better Medical Competitive Strengths & Weaknesses
Table 95. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 96. Vison Medical Major Business
Table 97. Vison Medical Tumour Ablation Devices Product and Services
Table 98. Vison Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vison Medical Recent Developments/Updates
Table 100. Vison Medical Competitive Strengths & Weaknesses
Table 101. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 102. Shanghai Maide Major Business
Table 103. Shanghai Maide Tumour Ablation Devices Product and Services
Table 104. Shanghai Maide Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shanghai Maide Recent Developments/Updates
Table 106. Shanghai Maide Competitive Strengths & Weaknesses
Table 107. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 108. HealthTronics Major Business
Table 109. HealthTronics Tumour Ablation Devices Product and Services
Table 110. HealthTronics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HealthTronics Recent Developments/Updates
Table 112. HealthTronics Competitive Strengths & Weaknesses
Table 113. J &J Basic Information, Manufacturing Base and Competitors
Table 114. J &J Major Business
Table 115. J &J Tumour Ablation Devices Product and Services
Table 116. J &J Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. J &J Recent Developments/Updates
Table 118. J &J Competitive Strengths & Weaknesses
Table 119. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 120. EDAP TMS Major Business
Table 121. EDAP TMS Tumour Ablation Devices Product and Services
Table 122. EDAP TMS Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EDAP TMS Recent Developments/Updates
Table 124. EDAP TMS Competitive Strengths & Weaknesses
Table 125. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 126. Sonacare Medical Major Business
Table 127. Sonacare Medical Tumour Ablation Devices Product and Services
Table 128. Sonacare Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sonacare Medical Recent Developments/Updates
Table 130. Sonacare Medical Competitive Strengths & Weaknesses
Table 131. Misonix Basic Information, Manufacturing Base and Competitors
Table 132. Misonix Major Business
Table 133. Misonix Tumour Ablation Devices Product and Services
Table 134. Misonix Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Misonix Recent Developments/Updates
Table 136. Misonix Competitive Strengths & Weaknesses
Table 137. Global Key Players of Tumour Ablation Devices Upstream (Raw Materials)
Table 138. Global Tumour Ablation Devices Typical Customers
Table 1. World Tumour Ablation Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Tumour Ablation Devices Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Tumour Ablation Devices Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Tumour Ablation Devices Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Tumour Ablation Devices Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumour Ablation Devices Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Tumour Ablation Devices Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Tumour Ablation Devices Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Tumour Ablation Devices Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Tumour Ablation Devices Players in 2025
Table 12. World Tumour Ablation Devices Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Tumour Ablation Devices Company Evaluation Quadrant
Table 14. Head Office of Key Tumour Ablation Devices Players
Table 15. Tumour Ablation Devices Market: Company Product Type Footprint
Table 16. Tumour Ablation Devices Market: Company Product Application Footprint
Table 17. Tumour Ablation Devices Mergers & Acquisitions Activity
Table 18. United States VS China Tumour Ablation Devices Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Tumour Ablation Devices Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Tumour Ablation Devices Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumour Ablation Devices Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 23. China Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumour Ablation Devices Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 26. Rest of World Based Tumour Ablation Devices Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Tumour Ablation Devices Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Tumour Ablation Devices Revenue Market Share (2021-2026)
Table 29. World Tumour Ablation Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Tumour Ablation Devices Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Tumour Ablation Devices Market Size by Type (2027-2032) & (USD Million)
Table 32. World Tumour Ablation Devices Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Tumour Ablation Devices Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 34. World Tumour Ablation Devices Market Size by Energy Source (2027-2032) & (USD Million)
Table 35. World Tumour Ablation Devices Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Tumour Ablation Devices Market Size Value by Procedure Type (2021-2026) & (USD Million)
Table 37. World Tumour Ablation Devices Market Size by Procedure Type (2027-2032) & (USD Million)
Table 38. World Tumour Ablation Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Tumour Ablation Devices Market Size by Application (2021-2026) & (USD Million)
Table 40. World Tumour Ablation Devices Market Size by Application (2027-2032) & (USD Million)
Table 41. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 42. Chongqing Haifu Medical Major Business
Table 43. Chongqing Haifu Medical Tumour Ablation Devices Product and Services
Table 44. Chongqing Haifu Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Chongqing Haifu Medical Recent Developments/Updates
Table 46. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 47. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 48. AngioDynamics Major Business
Table 49. AngioDynamics Tumour Ablation Devices Product and Services
Table 50. AngioDynamics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. AngioDynamics Recent Developments/Updates
Table 52. AngioDynamics Competitive Strengths & Weaknesses
Table 53. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Boston Scientific Major Business
Table 55. Boston Scientific Tumour Ablation Devices Product and Services
Table 56. Boston Scientific Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Boston Scientific Recent Developments/Updates
Table 58. Boston Scientific Competitive Strengths & Weaknesses
Table 59. Medtronic Basic Information, Manufacturing Base and Competitors
Table 60. Medtronic Major Business
Table 61. Medtronic Tumour Ablation Devices Product and Services
Table 62. Medtronic Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Medtronic Recent Developments/Updates
Table 64. Medtronic Competitive Strengths & Weaknesses
Table 65. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 66. Yigao Medical Major Business
Table 67. Yigao Medical Tumour Ablation Devices Product and Services
Table 68. Yigao Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yigao Medical Recent Developments/Updates
Table 70. Yigao Medical Competitive Strengths & Weaknesses
Table 71. Haijieya Basic Information, Manufacturing Base and Competitors
Table 72. Haijieya Major Business
Table 73. Haijieya Tumour Ablation Devices Product and Services
Table 74. Haijieya Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Haijieya Recent Developments/Updates
Table 76. Haijieya Competitive Strengths & Weaknesses
Table 77. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 78. Beijing Weierfu Major Business
Table 79. Beijing Weierfu Tumour Ablation Devices Product and Services
Table 80. Beijing Weierfu Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Beijing Weierfu Recent Developments/Updates
Table 82. Beijing Weierfu Competitive Strengths & Weaknesses
Table 83. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 84. Micro Tech Medical Major Business
Table 85. Micro Tech Medical Tumour Ablation Devices Product and Services
Table 86. Micro Tech Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Micro Tech Medical Recent Developments/Updates
Table 88. Micro Tech Medical Competitive Strengths & Weaknesses
Table 89. Better Medical Basic Information, Manufacturing Base and Competitors
Table 90. Better Medical Major Business
Table 91. Better Medical Tumour Ablation Devices Product and Services
Table 92. Better Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Better Medical Recent Developments/Updates
Table 94. Better Medical Competitive Strengths & Weaknesses
Table 95. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 96. Vison Medical Major Business
Table 97. Vison Medical Tumour Ablation Devices Product and Services
Table 98. Vison Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vison Medical Recent Developments/Updates
Table 100. Vison Medical Competitive Strengths & Weaknesses
Table 101. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 102. Shanghai Maide Major Business
Table 103. Shanghai Maide Tumour Ablation Devices Product and Services
Table 104. Shanghai Maide Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Shanghai Maide Recent Developments/Updates
Table 106. Shanghai Maide Competitive Strengths & Weaknesses
Table 107. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 108. HealthTronics Major Business
Table 109. HealthTronics Tumour Ablation Devices Product and Services
Table 110. HealthTronics Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HealthTronics Recent Developments/Updates
Table 112. HealthTronics Competitive Strengths & Weaknesses
Table 113. J &J Basic Information, Manufacturing Base and Competitors
Table 114. J &J Major Business
Table 115. J &J Tumour Ablation Devices Product and Services
Table 116. J &J Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. J &J Recent Developments/Updates
Table 118. J &J Competitive Strengths & Weaknesses
Table 119. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 120. EDAP TMS Major Business
Table 121. EDAP TMS Tumour Ablation Devices Product and Services
Table 122. EDAP TMS Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EDAP TMS Recent Developments/Updates
Table 124. EDAP TMS Competitive Strengths & Weaknesses
Table 125. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 126. Sonacare Medical Major Business
Table 127. Sonacare Medical Tumour Ablation Devices Product and Services
Table 128. Sonacare Medical Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Sonacare Medical Recent Developments/Updates
Table 130. Sonacare Medical Competitive Strengths & Weaknesses
Table 131. Misonix Basic Information, Manufacturing Base and Competitors
Table 132. Misonix Major Business
Table 133. Misonix Tumour Ablation Devices Product and Services
Table 134. Misonix Tumour Ablation Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Misonix Recent Developments/Updates
Table 136. Misonix Competitive Strengths & Weaknesses
Table 137. Global Key Players of Tumour Ablation Devices Upstream (Raw Materials)
Table 138. Global Tumour Ablation Devices Typical Customers
LIST OF FIGURES
Figure 1. Tumour Ablation Devices Picture
Figure 2. World Tumour Ablation Devices Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tumour Ablation Devices Total Revenue (2021-2032) & (USD Million)
Figure 4. World Tumour Ablation Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Tumour Ablation Devices Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 13. Tumour Ablation Devices Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 16. World Tumour Ablation Devices Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 18. China Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 23. India Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Tumour Ablation Devices by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumour Ablation Devices Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumour Ablation Devices Markets in 2025
Figure 27. United States VS China: Tumour Ablation Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tumour Ablation Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Tumour Ablation Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Tumour Ablation Devices Market Size Market Share by Type in 2025
Figure 31. Radiofrequency Ablation
Figure 32. Microwave Ablation
Figure 33. Cryoablation
Figure 34. Other
Figure 35. World Tumour Ablation Devices Market Size Market Share by Type (2021-2032)
Figure 36. World Tumour Ablation Devices Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 37. World Tumour Ablation Devices Market Size Market Share by Energy Source in 2025
Figure 38. Thermal
Figure 39. Cryogenic
Figure 40. World Tumour Ablation Devices Market Size Market Share by Energy Source (2021-2032)
Figure 41. World Tumour Ablation Devices Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World Tumour Ablation Devices Market Size Market Share by Procedure Type in 2025
Figure 43. Percutaneous
Figure 44. Laparoscopic
Figure 45. Open
Figure 46. World Tumour Ablation Devices Market Size Market Share by Procedure Type (2021-2032)
Figure 47. World Tumour Ablation Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Tumour Ablation Devices Market Size Market Share by Application in 2025
Figure 49. Liver Cancer
Figure 50. Lung Cancer
Figure 51. Breast Cancer
Figure 52. Other
Figure 53. World Tumour Ablation Devices Market Size Market Share by Application (2021-2032)
Figure 54. Tumour Ablation Devices Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Tumour Ablation Devices Picture
Figure 2. World Tumour Ablation Devices Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tumour Ablation Devices Total Revenue (2021-2032) & (USD Million)
Figure 4. World Tumour Ablation Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Tumour Ablation Devices Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Tumour Ablation Devices Revenue (2021-2032) & (USD Million)
Figure 13. Tumour Ablation Devices Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 16. World Tumour Ablation Devices Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 18. China Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 23. India Tumour Ablation Devices Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Tumour Ablation Devices by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumour Ablation Devices Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumour Ablation Devices Markets in 2025
Figure 27. United States VS China: Tumour Ablation Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tumour Ablation Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Tumour Ablation Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Tumour Ablation Devices Market Size Market Share by Type in 2025
Figure 31. Radiofrequency Ablation
Figure 32. Microwave Ablation
Figure 33. Cryoablation
Figure 34. Other
Figure 35. World Tumour Ablation Devices Market Size Market Share by Type (2021-2032)
Figure 36. World Tumour Ablation Devices Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 37. World Tumour Ablation Devices Market Size Market Share by Energy Source in 2025
Figure 38. Thermal
Figure 39. Cryogenic
Figure 40. World Tumour Ablation Devices Market Size Market Share by Energy Source (2021-2032)
Figure 41. World Tumour Ablation Devices Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World Tumour Ablation Devices Market Size Market Share by Procedure Type in 2025
Figure 43. Percutaneous
Figure 44. Laparoscopic
Figure 45. Open
Figure 46. World Tumour Ablation Devices Market Size Market Share by Procedure Type (2021-2032)
Figure 47. World Tumour Ablation Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Tumour Ablation Devices Market Size Market Share by Application in 2025
Figure 49. Liver Cancer
Figure 50. Lung Cancer
Figure 51. Breast Cancer
Figure 52. Other
Figure 53. World Tumour Ablation Devices Market Size Market Share by Application (2021-2032)
Figure 54. Tumour Ablation Devices Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
